The U.S. Food and Drug Administration (FDA) hosts a town hall discussion on the recent updates to the risk-based framework per FDA’s guidance titled “Use of International Standard ISO 10993-1, ‘Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process.’” This event is scheduled to begin at 1 p.m. ET on Sept. 9.
…